Editorial Board Members' Collection Series: Advances in Colorectal Cancer Diagnostics and Treatments
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 220
Special Issue Editors
Interests: drug development; hepatocellular cancer; pancreatic cancer; colorectal cancer; precision oncology; oncolytic viral therapy; apoptosis; Autophagy
Interests: metastatic colorectal cancer; liver tumor ablation; lung tumor ablation; intra-arterial hepatic therapies; radioembolization; debiri tace
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As academic editors for this Special Issue, we are seeking high-quality research papers on the latest advances in colorectal cancer diagnostics and treatment. Topics of interest include minimal residual disease (MRD), analysis of next-generation sequencing (NGS) both in early- and advanced-stage disease, and novel diagnostic strategies and therapeutic interventions both in preclinical and clinical setting. As this is a rapidly growing field, we believe that publishing relevant papers will not only benefit our readers but also contribute to the advancement of knowledge in this important area of research.
We would be grateful if you could consider submitting any research papers that you have written on the topic of colorectal cancer diagnostics and treatments to the Cancers journal for review and potential publication.
In this Special Issue, original research articles and reviews are both welcome. We look forward to receiving your submission and hope to work with you in the future.
Dr. Devalingam Mahalingam
Prof. Dr. Constantinos T. Sofocleous
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- diagnosis
- novel treatment
- minimal residual disease (MRD)
- next-generation sequencing (NGS)
- preclinical and clinical trials in cancer
